The incidence of mandible tumors at four weeks was 25% (3/12) for mice injected with PC3-PMSA/KLK4 cells, in contrast to 83% (10/12) for PC3-PMSA/Vec tumor cells (Figure 4C). This evidence concerns the gene KLK4 and neoplasm.